Publication | Closed Access
HER2 status on persistent disseminated tumor cells after adjuvant therapy may differ from initial HER2 status on primary tumor.
59
Citations
16
References
2009
Year
HER2-positive DTCs can be detected in patients with HER2-negative tumors, even after adjuvant therapy. Such patients may benefit from (secondary) HER2-targeted therapy in an adjuvant setting.
| Year | Citations | |
|---|---|---|
Page 1
Page 1